WARRICK 1624 1624 (Griseofulvin (ultramicrocrystalline) 330 mg)

Pill imprint WARRICK 1624 1624 has been identified as Griseofulvin (ultramicrocrystalline) 330 mg.

Griseofulvin is used in the treatment of tinea capitis; dermatophytosis; onychomycosis, toenail; tinea barbae; tinea cruris (and more), and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Griseofulvin 330 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for WARRICK 1624 1624 (Griseofulvin (ultramicrocrystalline) 330 mg)

Griseofulvin (ultramicrocrystalline) 330 mg WARRICK 1624 1624
Griseofulvin (ultramicrocrystalline)
Imprint:
WARRICK
1624 1624
Strength:
330 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Miscellaneous antifungals
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Martec Pharmaceuticals Inc

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web5)